Is XBIT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for XBIT. It does not provide personalized investment advice.

XBIT (XBiotech Inc) Stock Analysis - Financials

XBiotech Inc (XBIT) is a publicly traded Healthcare sector company. As of June 15, 2026, XBIT trades at $2.37 with a market cap of $71.34M and a P/E ratio of -1.61. XBIT moved +1.28% today. Year to date, XBIT is -2.09%; over the trailing twelve months it is -15.22%. Its 52-week range spans $2.09 to $8.32. Rallies surfaces XBIT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are XBIT's key financials?

XBIT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. XBIT recently traded at $2.37. Market cap is $71.34M. P/E ratio is -1.61. Revenue is $0.

XBIT Key Metrics

Key financial metrics for XBIT
Metric	Value
Price	$2.37
Market Cap	$71.34M
P/E Ratio	-1.61
EPS	$-1.49
Dividend Yield	2.10%
52-Week High	$8.32
52-Week Low	$2.09
Volume	12.85K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-45.54M
Gross Margin	0.00%

XBIT Analyst Consensus

XBIT analyst coverage data. Average price target: $0.00.

Common questions about XBIT

What are XBIT's key financials?: XBIT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. XBIT recently traded at $2.37. Market cap is $71.34M. P/E ratio is -1.61. Revenue is $0.
Is XBIT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for XBIT. It does not provide personalized investment advice.